Our regulatory expertise places us at a great advantage to effectively and efficiently complete IND/CTA submission and/or BLA/MAA submission.  No matter what the target market,  our dedicated experts enable us to provide appropriate and timely regulatory support needed for expedited approval of target biosimilar products.